A U.S. cancer research center and a software company reached
agreements with Cuban partners during a two-day trade mission to Cuba
led by New York Governor Andrew Cuomo in the first trip of its kind
since the rapprochement between Washington and Havana.
The Roswell Park Cancer Institute of Buffalo, New York, on Tuesday
signed an agreement with Cuba's Center for Molecular Immunology to
develop a lung cancer vaccine with a clinical trial in the United
States, Roswell Chief Executive Officer Candace Johnson said.
In addition, New York City-based Infor, previously known as Infor
Global Solutions Inc, has found Cuban partners to resell its
software in Cuba, CEO Charles Phillips said.
Both announcements were made at the airport just before Cuomo and a
delegation of 18 business leaders and academics boarded their return
flight to New York.
No comments:
Post a Comment